
						
							
						
						
							<!--
							google_ad_client = "pub-5806585833518451";
							/* 300x250, created 6/2/09 - iposol_ipo_detail_top */
							google_ad_slot = "4379562531";
							google_ad_width = 300;
							google_ad_height = 250;
									-->
							
							
							
						

						Incorporated in 2002, Syncom Healthcare Ltd is a pharmaceutical company based in central India. Syncom is in the business of manufacturing, marketing & trading of pharmaceuticals formulations under its own brands of Ethical, OTC, Generic and Herbal market segment. Syncom have over 250 products available in various dosage forms including Tablets, Capsules, Liquids, Ointments, Eye/Ear Drops, Dry Syrup, Herbal Products, Protein Powder and External Preparations.Apart from their own Marketing setup (OTC, Generics and Ethical Divisions), Syncom Healthcare is also a leading Contract Manufacturing company catering to various domestic and multinational companies. Syncom have a range of over 400 products and can develop customized products as per the needs of the customer and deliver the products at short notice. Syncom Healthcare manufacturing premises spans is over 1,25,000 sq.fts.The proceeds of the issue are proposed to be utilized for its various expansion plan which include setting up of a new manufacturing unit at Indore SEZ for manufacturing various pharmaceutical formulations, undertaking various upgradation/modernization of manufacturing facilities at Dehradun plant and to set up an export office at Mumbai.

						
						
							
						
						

						Company Promoters:1. Mr. Ajay Bankda, aged 48 years has completed his Master of Commerce in the year 1981 from the Vikram University, Ujjain. Since 2002 he is working as Managing Director of Syncom Healthcare Limited.  2. Mrs. Jyoti Bankda, aged 42 years has completed her SSC examination in the year 1982 from Maharashtra State Board of Secondary & Higher Secondary Education, Pune.

						Company Financials:
   ParticularsFor the year/period ended (Rs. in Lacs)
      
   31-Jul-09 31-Mar-0931-Mar-0831-Mar-0731-Mar-06
     Total Income2067.806056.495495.283072.591933.35
     Profit After Tax (PAT)160.19378.04366.52274.4824.37
  

						
							<!--
								google_ad_client = "pub-5806585833518451";
								/* 300x250, created 9/3/09 - IPO Detail Center */
								google_ad_slot = "7910498455";
								google_ad_width = 300;
								google_ad_height = 250;
								-->
							
							
							
						

						Objects of the Issue:The objects of the Issue are:1. To set up our new manufacturing unit at Indore SEZ for manufacturing of various pharmaceuticals formulations;2. To undertake the upgradation/modernization of manufacturing facilities at Dehradun Plant;3. To Meet Working Capital Requirements;4. To set up an Export Office at Mumbai;5. To undertake “Brand & Product Registration and ApprovalÂ”;6. To meet General Corporate Purpose; and7. To meet Issue Expenses.

						Issue Detail:
						Â Â Â»Â»Â Â Issue Open: Jan 27, 2010 - Jan 29, 2010
							Â Â Â»Â»Â Â Issue Type: Book Built Issue IPO
							Â Â Â»Â»Â Â Issue Size: 7,500,000 Equity Shares of Rs 10 aggregating up to Rs 56.25 Cr
							
							
							Â Â Â»Â»Â Â Face Value: Rs 10 Per Equity Share
							Â Â Â»Â»Â Â Issue Price: Rs. 65 - Rs. 75 Per Equity Share
							Â Â Â»Â»Â Â Market Lot: 90 Shares
							Â Â Â»Â»Â Â Minimum Order Quantity: 90 Shares
							Â Â Â»Â»Â Â Listing At: BSE, NSE
						

						Syncom Healthcare Limited IPO Grading / Rating
CARE has assigned an IPO Grade 2 to Syncom Healthcare IPO. This means as per CARE, company has Below Average Fundamentals. CARE assigns IPO gradings on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals. Click here to download the CARE IPO Grading Document for Syncom Healthcare IPO.
Check IPO Ratings from other stock analysts.


						


						
							
						

						
							Issue Subscription Detail / Current Bidding StatusNumber of Times Issue is Subscribed (BSE + NSE)As on Date & TimeQIBNIIRIITotalShares Offered / Reserved3,750,0001,125,0002,625,0007,500,000Day 1 - Jan 27, 2010 17:00 IST0.26431.05840.53750.4800Day 2 - Jan 28, 2010 17:00 IST0.46671.13440.97230.7400Day 3 - Jan 29, 2010 17:00 IST0.989716.60296.24815.1721
						
					
